Conference
  • Date: 9-10 October 2024
  • City: Basel
  • Country: Switzerland
  • Address: Hall 1.1, Messe Basel, Switzerland
BioTechX Europe 2024
BioTech X EUROPE ONTOFORCE DISQOVER-1

We are excited to announce that we will be participating in the BioTechX Europe 2024 in Basel, Switzerland to showcase our flagship product, DISQOVER. As a leading provider of life sciences data and knowledge platforms, we are dedicated to helping organizations accelerate research and drug development to improve patient outcomes. 

DISQOVER is a cutting-edge platform designed specifically for life sciences organizations, leveraging semantic technology and an ontology-based knowledge graph to help users unlock hidden insights from their data. With over 10,000 users globally, DISQOVER is trusted by many leading pharmaceutical and biotech companies to accelerate research and drug development. We are thrilled to have the opportunity to demonstrate DISQOVER's powerful features and benefits to attendees at BioTechX Europe 2024, where there will be joining more than 1,500 leaders from across the pharmaceutical, biotech, and healthcare sectors for discussions on digital transformation, precision medicine, and drug development.


Panel discussion on Wednesday 9 October 2024 at 17:25 - Theater 9

moderated by ONTOFORCE:
GenAI for Drug Development: Data, Expertise, Systems

Discussion on challenges and best practices

In this insightful panel talk, experts from the fields of artificial intelligence, life sciences, and pharmaceuticals converge to explore the potent intersection of GenAI and drug discovery. With a primary focus on leveraging data assets, optimizing human expertise, and refining computational systems, the discussion will dive deeper into the opportunities and hurdles in the development of artificial intelligence.

The panelists will share their experiences and insights, examining the multifaceted challenges inherent in the growth and application of GenAI along the drug development journey. From data crawling to data integration to prediction, attendees will gain valuable perspectives on navigating the complexities of GenAI applications, from assistant to self-decision systems.

Moreover, the panel will highlight best practices gleaned from successful initiatives, offering practical strategies for implementing such applications along the drug discovery pipelines. Through an engaging exchange of ideas and real-world examples, attendees will emerge equipped with actionable insights to drive innovation and accelerate the pace of therapeutic breakthroughs in the pharmaceutical industry.”

Berenice Wulbrecht  ONTOFORCE

Bérénice Wulbrecht

Moderator
VP Solutions Enablement
ONTOFORCE

Mathew Woodwark Astra Zeneca ONTOFORCE-1

Matthew Woodwark

Head of Data Standards and Interoperability, R&D Data Office, AstraZeneca

Michel Dumontier

Michel Dumontier

Distinguished Professor at Universiteit Maastricht, and co-founder of FAIR

Allan Christian Shaw  Corporate Vice President at Novo Nordisk   ONTOFORCE

Allan Shaw

Corporate Vice President, Data & Knowledge Discovery, Novo Nordisk


ONTOFORCE BioTechX Europe 2023

Join ONTOFORCE at BioTechX Europe 2024 | Booth: 334

Attendees will have the opportunity to see DISQOVER in action and learn more about how it can help them unlock hidden insights from their data to improve patient outcomes. DISQOVER's semantic technology and ontology-based knowledge graph enables more efficient data exploration and analysis, making it a trusted platform among leading pharmaceutical and biotech companies. 

Book a meeting ahead with us to secure time with our experts. Send an email to marketing@ontoforce.com with your contact details.

Check out ONTOFORCE in action at BioTechX Europe in 2023